Formerly, Chief Neurosurgical Consultant of Craig Hospital and the Craig Center for Spinal Cord Injury Research
Chairman/President – Falci Adaptive Motorsports
AB Princeton University, MD Georgetown University, Residency Georgetown University
Larry Gold, PhD - Chairman of the Board
Founder and former CEO and Chairman of the Board of SomaLogic
Founder, NeXagen/NeXstar (acquired by Gilead)
Co-founder, Synergen (acquired by Amgen)
Professor, Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder (Chair, 1988-1992)
BS Yale University, PhD University of Connecticut
John Swindle, PhD – Chief Scientific Officer
Head of Research at Rare Disease Sciences
Cofounder, President, and CEO of CompleGen, a small molecule drug discovery company
Associate professor, University of Washington Department of Pathobiology; member of Seattle Biomedical Research Institute
Associate professor of Microbiology and Immunology at the University of Tennessee (1986-1996)
BS University of Oregon, PhD University of Utah
Larry Hunter, PhD – Chief Technology Officer
Professor of Pediatrics and of Computer Science, University of Chicago (starting summer 2024)
Professor of Biomedical Informatics, Pharmacology, and Computer Science; Founder of the Computational Bioscience PhD program; University of Colorado (2000-2023)
Staff scientist and Director of the Machine Learning Program, NLM/NIH (1989-2000)
Founder and first President, International Society for Computational Biology
BA and PhD, Yale University
Todd Gander, MBA – Chief Business Officer
Principal, Vigesco LLC strategy consulting
Strategy and corporate development roles across a range of life sciences companies including NeXstar, SomaLogic, Covidien (Medtronic), Biodesix
Previous experience: Boston Consulting Group (New York) and Empire Blue Cross and Blue Shield
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.